Potential for receptor-based antiviral drugs against SARS
Lancet
.
2003 Jul 5;362(9377):77.
doi: 10.1016/S0140-6736(03)13818-4.
Authors
Richard K Williams
,
Curtis L Yeager
,
Kathryn V Holmes
PMID:
12853208
PMCID:
PMC7134702
DOI:
10.1016/S0140-6736(03)13818-4
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents / therapeutic use*
CD13 Antigens / antagonists & inhibitors*
Humans
Severe Acute Respiratory Syndrome / drug therapy*
Substances
Antiviral Agents
CD13 Antigens